INDP vs MSCI · $7.4M cap vs P/E 37, rev $1.72B
Indaptus Therapeutics Inc (INDP) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Indaptus Therapeutics Inc (INDP) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
INDP does not have a complete income-statement cache yet.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
INDP currently screens at market cap $7.4M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the INDP and MSCI stock pages for the full models.
Not investment advice.